Showing results (21-30 of 114) with videos related to
Sort By:
Pageof 12
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 25, 2003
Influence of delayed initiation of cyclosporine on everolimus pharmacokinetics in de novo renal transplant patientsJohn M Kovarik, Jacques Dantal, Giovanni Civati, et al.Journal of Nephrology|May 23, 2026
Dapagliflozin corrects hypomagnesemia in kidney-transplant patientsDouchka Guillot, Thomas Dejoie, Clarisse Kerleau, et al.Transplantation|December 16, 2004
Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipientsStefan Vítko, Raimund Margreiter, Willem Weimar, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 12, 2010
Development of initial idiopathic nephrotic syndrome and post-transplantation recurrence: evidence of the same biological entityLudmilla Le Berre, Sarah Bruneau, Karine Renaudin, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|October 2, 2015
Vitamin D deficiency is an independent risk factor for PTDM after kidney transplantationAwena Le Fur, Marie-Cécile Fournier, Florence Gillaizeau, et al.Nephrologie & Therapeutique|March 4, 2022
[Prevalence of iron deficiency in patients with non-dialysis chronic kidney disease: The CARENFER national, multicentre, observational study]Gabriel Choukroun, Isabelle Kazes, Jacques Dantal, et al.Kidney International|November 2, 2020
Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypesAmaury Dujardin, Mélanie Chesneau, Florian Dubois, et al.Autoimmunity Reviews|September 20, 2015
Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidencePatrick Cherin, Isabelle Marie, Mauricette Michallet, et al.Transplantation|December 16, 2010
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipientsJohn M Kovarik, Jürg U Steiger, Josep M Grinyo, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 16, 2013
Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosisSeverine Beaudreuil, Xiaomeng Zhang, Faycal Kriaa, et al.Pageof 12